395 related articles for article (PubMed ID: 33485506)
21. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
[No Abstract] [Full Text] [Related]
22. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial.
Cello JP; Ring EJ; Olcott EW; Koch J; Gordon R; Sandhu J; Morgan DR; Ostroff JW; Rockey DC; Bacchetti P; LaBerge J; Lake JR; Somberg K; Doherty C; Davila M; McQuaid K; Wall SD
Ann Intern Med; 1997 Jun; 126(11):858-65. PubMed ID: 9163286
[TBL] [Abstract][Full Text] [Related]
23. Treatment outcomes of percutaneous transhepatic variceal embolization versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding.
Zhang K; Sun X; Wang G; Zhang M; Wu Z; Tian X; Zhang C
Medicine (Baltimore); 2019 May; 98(18):e15464. PubMed ID: 31045824
[TBL] [Abstract][Full Text] [Related]
24. Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding.
Xue H; Zhang M; Pang JX; Yan F; Li YC; Lv LS; Yuan J; Palikhe M; Li WZ; Wang ZL
World J Gastroenterol; 2012 Dec; 18(48):7341-7. PubMed ID: 23326143
[TBL] [Abstract][Full Text] [Related]
25. Long-term results of variceal bleeding management in 302 patients with chronic extrahepatic portal vein obstruction.
Chen H; He C; Lv Y; Fan J; Tang S; Niu J; Yuan J; Luo B; Guo W; Yin Z; Han G
J Gastroenterol Hepatol; 2020 Jun; 35(6):1049-1056. PubMed ID: 31677186
[TBL] [Abstract][Full Text] [Related]
26. Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage.
Hermie L; Dhondt E; Vanlangenhove P; Hoste E; Geerts A; Defreyne L
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1441-1446. PubMed ID: 30048333
[TBL] [Abstract][Full Text] [Related]
27. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
[TBL] [Abstract][Full Text] [Related]
28. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt.
Choi YH; Yoon CJ; Park JH; Chung JW; Kwon JW; Choi GM
Korean J Radiol; 2003; 4(2):109-16. PubMed ID: 12845306
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the Effects of TIPS versus BRTO on Bleeding Gastric Varices: A Meta-Analysis.
Wang ZW; Liu JC; Zhao F; Zhang WG; Duan XH; Chen PF; Yang SF; Li HW; Chen FW; Shi HS; Ren JZ
Can J Gastroenterol Hepatol; 2020; 2020():5143013. PubMed ID: 32104670
[TBL] [Abstract][Full Text] [Related]
30. Transjugular intrahepatic portosystemic shunt with or without variceal embolization to prevent variceal rebleeding: an updated meta-analysis.
Abuelazm MT; Cheema HA; Jafar U; Awad AK; Atef M; Abdalshafy H; Alashwah M; Shahid A; Awan RU; Afifi AM; Jalal PK; Aziz H
Expert Rev Gastroenterol Hepatol; 2023; 17(7):741-751. PubMed ID: 37306478
[TBL] [Abstract][Full Text] [Related]
31. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization.
Chen S; Li X; Wei B; Tong H; Zhang MG; Huang ZY; Cao JW; Tang CW
Radiology; 2013 Sep; 268(3):900-6. PubMed ID: 23657891
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of Transjugular Intrahepatic Portosystemic Shunt and Gastric Coronary Vein Embolization for Variceal Bleeding in Cirrhotic Portal Hypertension.
Mukhiya G; Han X; Jiao D; Bi Y; Pokhrel G; Liu Z; Li Z; He Y
Clin Med Res; 2023 Sep; 21(3):144-154. PubMed ID: 37985166
[No Abstract] [Full Text] [Related]
33. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis.
Wu W; Zhang H; Zeng Z; Wang X; Kong D
Scand J Gastroenterol; 2022 Dec; 57(12):1494-1502. PubMed ID: 35802771
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Transjugular Intrahepatic Portosystemic Shunt with Covered Stent and Balloon-Occluded Retrograde Transvenous Obliteration in Managing Isolated Gastric Varices.
Kim SK; Lee KA; Sauk S; Korenblat K
Korean J Radiol; 2017; 18(2):345-354. PubMed ID: 28246514
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Vascular Plugs and Pushable Coils for Variceal Embolization After TIPS.
Sarwar A; Esparaz AM; Tapper EB; Brook OR; Grunwald D; Malik R; Ahmed M
AJR Am J Roentgenol; 2017 Mar; 208(3):650-655. PubMed ID: 27959638
[TBL] [Abstract][Full Text] [Related]
37. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker.
Chen Y; Ma X; Zhang X; Luo J; An L; Zhang Y; Chang X; Dong Z; Zhang W; Kong H; Zhao J; Ding H; Liu F; Yang Y
Hepatol Int; 2022 Dec; 16(6):1379-1389. PubMed ID: 36255564
[TBL] [Abstract][Full Text] [Related]
38. Use of concomitant variceal embolization and prophylactic antiplatelet/anticoagulative in transjugular intrahepatic portosystemic shunting: A retrospective study of 182 cirrhotic portal hypertension patients.
Tang Y; Zheng S; Yang J; Bao W; Yang L; Li Y; Xu Y; Yang J; Tong Y; Gao J; Tang C
Medicine (Baltimore); 2017 Dec; 96(49):e8678. PubMed ID: 29245228
[TBL] [Abstract][Full Text] [Related]
39. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients.
Meddi P; Merli M; Lionetti R; De Santis A; Valeriano V; Masini A; Rossi P; Salvatori F; Salerno F; de Franchis R; Capocaccia L; Riggio O
Hepatology; 1999 Apr; 29(4):1074-7. PubMed ID: 10094949
[TBL] [Abstract][Full Text] [Related]
40. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
